User:Mr. Ibrahem/Vonoprazan/amoxicillin/clarithromycin

Vonoprazan/amoxicillin/clarithromycin, sold under the brand name Vonosap among others, is a co-packaged medication used to treat Helicobacter pylori (H. pylori) infection. It is taken by mouth.

Common side effects include diarrhea, vaginal yeast infection, headache, abdominal pain, and high blood pressure. Other side effects may include allergic reaction, Clostridioides difficile-associated diarrhea, QT prolongation. Use is generally not recommended in pregnancy. It contains vonoprazan, a potassium-competitive acid blocker; amoxicillin, a beta-lactam antibiotic; and clarithromycin, a macrolide antibiotic.

The combination was approved for medical use in Japan in 2016, and the United States in 2022. In the United States a course of treatment costs about 860 USD as of 2022. As of 2022 it is not avaliable in Europe or the United Kingdom.